Listing deficiency & delisting notices
402 filings across 4 categories (listing deficiency notice, delisting determination, listing compliance regained and voluntary delisting) in the last 90 days. The most common was listing deficiency notice (294).
Latest filings
| Filed | Issuer | Event | Classified excerpt | Source |
|---|---|---|---|---|
| CNTYCentury Casinos Inc | Listing deficiency notice | “On October 19, 2026, Century Casinos, Inc. received a deficiency notice from the Nasdaq Listing Qualifications staff notifying the Company that for the prior 30 consecutive business days, the Company's common stock did not maintain the minimum Market Value of Listed Securities of $35 million required by Nasdaq Listing Rule 5550(b)(2).” | 8-K ↗ | |
| MDCXMedicus Pharma Ltd. | Delisting determinationListing compliance regained | “On October 20, 2026, the Company received a delisting determination letter from Nasdaq indicating that the Company had not regained compliance with the Minimum Bid Price Requirement and that Nasdaq had determined to delist the Company's common shares and warrants from The Nasdaq Capital Market.” | 8-K ↗ | |
| DFNST3 Defense Inc. | Listing deficiency noticeListing compliance regained | “On August 20, 2026, the Company received a written notice from Nasdaq notifying the Company that it is not in compliance with the minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5450(b)(1)(A) for continued listing on The Nasdaq Global Market.” | 8-K ↗ | |
| TCRTAlaunos Therapeutics, Inc. | Listing compliance regained | “On October 22, 2026, the Company received a letter from Nasdaq's Office of General Counsel advising that the Staff has confirmed that the Company has regained compliance with the Stockholders' Equity Requirement. As a result, Nasdaq has determined that this matter is now closed, the hearing before the Panel scheduled for November 10, 2026 has been cancelled, and the Company's common stock will continue to be listed and traded on The Nasdaq Capital Market.” | 8-K ↗ | |
| CTORCitius Oncology, Inc. | Listing deficiency notice | “On October 19, 2026, Citius Oncology, Inc. received formal notice that Nasdaq granted its request for an extension through April 19, 2027 to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”).” | 8-K ↗ | |
| POLAPolar Power, Inc. | Listing deficiency noticeListing compliance regained | “As previously disclosed, on May 1, 2026, Polar Power, Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of US$2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.” | 8-K ↗ | |
| LASELaser Photonics Corporation | Listing deficiency notice | “In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until April 19, 2027, to regain compliance with the minimum bid price requirement. The Company will regain compliance if, at any time during this 180-day period, the closing bid price of its common stock is at least $1.00 per share for a minimum of 10 consecutive business days.” | 8-K ↗ | |
| DFLIDragonfly Energy Holdings Corp. | Listing deficiency notice | “The Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC, indicating that the Company was not in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company's stockholders' equity (deficit) of $(184,000) ... was below the required minimum of $2.5 million.” | 8-K ↗ | |
| FJDIARC Group Securities Acquisition I | Listing deficiency notice | “The Notice additionally indicates that, pursuant to the Listing Rules, the Company has 45 calendar days to submit a plan to regain compliance, and that the Company's plan must be submitted to Nasdaq no later than December 4, 2026.” | 8-K ↗ | |
| AKBAAkebia Therapeutics, Inc. | Listing deficiency notice | “On October 21, 2026, Akebia Therapeutics, Inc. received a deficiency letter from Nasdaq notifying the Company that, for the last 30 consecutive business days, the bid price for the Company's common stock had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2).” | 8-K ↗ | |
| ENOB | Listing deficiency noticeDelisting determinationVoluntary delisting | “On October 21, 2026, Lunai Bioworks Inc. received a letter from Nasdaq notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires ... stockholders' equity of at least $2,500,000.” | 8-K ↗ | |
| STEMStem, Inc. | Listing deficiency notice | “On October 20, 2026, the Company received from the NYSE a non-compliance letter confirming that the Company is not in compliance with the requirement of Section 802.01B of the NYSE Manual that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and stockholders' equity of not less than $50.0 million.” | 8-K ↗ | |
| INVInnventure, Inc. | Listing deficiency notice | “On October 23, 2026, Innventure, Inc. received a letter from Nasdaq informing the Company that, based upon the closing bid price of the Company's common stock for the thirty consecutive business days ended October 22, 2026, the Company no longer satisfies the continued listing requirement to maintain a minimum bid price of $1.00 per share under Nasdaq Listing Rule 5450(a)(1. The Company has been provided an initial period of 180 calendar days, or until April 21, 2027, to regain compliance.” | 8-K ↗ | |
| AAMEAtlantic American Corp | Listing deficiency noticeDelisting determination | “The Staff Determination was issued because the Company had not filed its Annual Report on Form 10-K for the year ended December 31, 2025 and its Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2026 and June 30, 2026 by October 12, 2026, which was the last day of the 180-day extension period previously granted by Nasdaq.” | 8-K ↗ | |
| TRUGTruGolf Holdings, Inc. | Listing deficiency noticeListing compliance regained | “Nasdaq ... [previously notified] the Company that ... the Company's stockholders' equity was $2,060,281, and therefore, the Company did not satisfy the minimum stockholders' equity requirement ... under Nasdaq Listing Rule 5550(b)(1), which requires stockholders' equity of at least $2,500,000.” | 8-K ↗ | |
| SNESSenesTech, Inc. | Listing deficiency notice | “On October 20, 2026, SenesTech, Inc. received a letter from Nasdaq notifying the Company that the bid price for its common stock had closed below $1.00 per share for the previous 30 consecutive business days and that the common stock no longer meets the minimum bid price requirement for continued listing under Nasdaq Listing Rule 5550(a)(2).” | 8-K ↗ | |
| TCRTAlaunos Therapeutics, Inc. | Listing deficiency noticeDelisting determinationListing compliance regained | “The Company received a written notice ... notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders' equity for continued listing.” | 8-K ↗ | |
| VAIValor Energy Incorporated | Listing deficiency notice | “On August 21, 2026, the Company received a notification letter from The Nasdaq Stock Market LLC... which notified the Company of its non-compliance with the minimum stockholders' equity requirement... Under the Rules, the Company was given 45 calendar days to submit a plan to regain compliance.” | 8-K ↗ | |
| VVOSVivos Therapeutics, Inc. | Listing compliance regained | “On October 20, 2026, the Company received a letter from the Staff stating that, based on the Company's Current Report on Form 8-K filed October 19, 2026, the Staff has determined that the Company complies with the minimum stockholders' equity requirement of Nasdaq Listing Rule 5550(b)(1).” | 8-K ↗ | |
| No ticker CIK 0001880613 | Delisting determinationVoluntary delisting | “As previously disclosed, on October 1, 2026, the Company received a notice (the "Delist Determination") from Nasdaq indicating that based on the Company's failure to comply with Nasdaq Listing Rule 5550(b)(1), Nasdaq had determined to delist the Common Stock and trading of the Common Stock on Nasdaq has been suspended since October 5, 2026.” | 8-K ↗ | |
| XWELXWELL, Inc. | Listing deficiency notice | “Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a compliance period of 180 calendar days, or until April 5, 2027, to regain compliance with the Minimum Bid Price Requirement.” | 8-K ↗ | |
| BZHBeazer Homes USA, Inc. New | Voluntary delisting | “The Company requested that the New York Stock Exchange ... file with the SEC an application on Form 25 to delist and deregister the Shares ... [and] expects to file ... Form 15 requesting the termination of registration.” | 8-K ↗ | |
| MEDSDataMeds AI, Inc. | Listing deficiency noticeListing compliance regained | “On April 13, 2026, the Company received a deficiency letter ... notifying the Company that ... the Company no longer satisfied the $2,500,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1), and that ... the Company also did not meet the alternative compliance standards under that Rule.” | 8-K ↗ | |
| SHFSSHF Holdings, Inc. | Listing deficiency notice | “On October 20, 2026, SHF Holdings, Inc. received a letter from Nasdaq stating that the Company is eligible for an additional 180 calendar days, or until April 19, 2027, to regain compliance with Nasdaq's requirement to maintain a minimum closing bid price of $1.00 per share for its Class A common stock.” | 8-K ↗ | |
| SEGGSports Entertainment Gaming Global Corporation | Listing deficiency noticeDelisting determination | “On October 14, 2026, Sports Entertainment Gaming Global Corporation received a letter from Nasdaq notifying the Company that, because it has not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, it has not regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the SEC.” | 8-K ↗ |
GET /stocks/filings/8-K/vX/disclosures?tertiary_category=listing_deficiency_notice&filing_date.gte=2026-07-28&sort=filing_date.desc&limit=1000GET /stocks/filings/8-K/vX/disclosures?tertiary_category=delisting_determination&filing_date.gte=2026-07-28&sort=filing_date.desc&limit=1000GET /stocks/filings/8-K/vX/disclosures?tertiary_category=listing_compliance_regained&filing_date.gte=2026-07-28&sort=filing_date.desc&limit=1000GET /stocks/filings/8-K/vX/disclosures?tertiary_category=voluntary_delisting&filing_date.gte=2026-07-28&sort=filing_date.desc&limit=1000Each category is a separate request; rows are merged and de-duplicated by filing.
{
"status": "OK",
"results": [
{
"tickers": [
"CNTY"
],
"cik": "0000911147",
"accession_number": "0000911147-26-000051",
"filing_date": "2026-10-23",
"primary_category": "regulatory_and_compliance",
"secondary_category": "exchange_listing",
"tertiary_category": "listing_deficiency_notice",
"supporting_text": "On October 19, 2026, Century Casinos, Inc. received a deficiency notice from the Nasdaq Listing Qualifications staff notifying the Company that for the prior 30 consecutive business days, the Company's common stock did not maintain the minimum Market Value of Listed Securities of $35 million required by Nasdaq Listing Rule 5550(b)(2).",
"filing_url": "https://www.sec.gov/Archives/edgar/data/911147/0000911147-26-000051.txt"
},
{
"tickers": [
"FJDI",
"FJDIR",
"FJDIU",
"FJDIW"
],
"cik": "0002094712",
"accession_number": "0001493152-26-048253",
"filing_date": "2026-10-23",
"primary_category": "regulatory_and_compliance",
"secondary_category": "exchange_listing",
"tertiary_category": "listing_deficiency_notice",
"supporting_text": "The Notice additionally indicates that, pursuant to the Listing Rules, the Company has 45 calendar days to submit a plan to regain compliance, and that the Company's plan must be submitted to Nasdaq no later than December 4, 2026.",
"filing_url": "https://www.sec.gov/Archives/edgar/data/2094712/0001493152-26-048253.txt"
}
]
}
// trimmed to 2 resultsShowing the 25 most recent of 402Query this data with the API
What these filings mean
- Listing deficiency notice
- Notice of failure to satisfy continued listing requirements with cure period.
- Delisting determination
- Exchange determination to delist securities with effective date and reasons.
- Listing compliance regained
- Regained listing compliance after previous deficiency notice.
- Voluntary delisting
- Voluntary decision to delist with rationale and alternative trading arrangements.
Usually filed under 8-K Item 3.01.
How this page works
- Every 8-K disclosure from the last 90 days is classified, and those in the categories above are listed here.
- One row per filing: a filing in several categories appears once.
- Labels are assigned automatically from the filing text, so always check the linked 8-K.
Other 8-K events
- CEO departures
- CFO & executive departures
- Stock splits
- Merger agreements & completions
- Share buyback programs
- Dividend declarations
- Earnings releases
- Guidance updates
- Clinical trial results
- Regulatory decisions
- Bankruptcy filings
- Financial restatements
- Auditor changes
- Cybersecurity incidents
- Layoffs & restructuring
Frequently asked questions
What is an SEC Form 8-K?
An 8-K is how a public company tells investors about a major event between its quarterly reports. Companies usually have four business days to file one.
How recent is this listing deficiency & delisting notices list?
It covers 8-K filings from the last 90 days, classified as listing deficiency & delisting notices and sorted newest first. The Massive 8-K disclosures API has the full, continuously updated record.
Build with AI
Track these filings with your agent
This page is built from the Massive 8-K disclosures endpoint. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check the 8-K disclosures endpoint once a day for new filings classified as listing deficiency & delisting notices (query each of listing_deficiency_notice, delisting_determination, listing_compliance_regained, voluntary_delisting as a separate tertiary_category request) and tell me about each new one, with the company, filing date, excerpt and SEC link.
Live market data from the Massive API and MCP.Get a free API key
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.